ID: ALA1778054

Max Phase: Preclinical

Molecular Formula: C40H73NO13

Molecular Weight: 776.02

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C3CCC3)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@]1(C)O

Standard InChI:  InChI=1S/C40H73NO13/c1-13-28-40(10,48)33(44)22(4)30(42)20(2)18-38(8,47)35(54-37-31(43)27(17-21(3)50-37)41(11)26-15-14-16-26)23(5)32(24(6)36(46)52-28)53-29-19-39(9,49-12)34(45)25(7)51-29/h20-35,37,42-45,47-48H,13-19H2,1-12H3/t20-,21-,22+,23+,24-,25+,27+,28-,29+,30+,31-,32+,33-,34+,35-,37+,38-,39-,40-/m1/s1

Standard InChI Key:  JPAUHMANUJAQEP-QNZGYDPESA-N

Associated Targets(non-human)

Motilin receptor 232 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 776.02Molecular Weight (Monoisotopic): 775.5082AlogP: 2.50#Rotatable Bonds: 8
Polar Surface Area: 197.07Molecular Species: BASEHBA: 14HBD: 6
#RO5 Violations: 3HBA (Lipinski): 14HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.46CX Basic pKa: 9.60CX LogP: 2.83CX LogD: 0.64
Aromatic Rings: 0Heavy Atoms: 54QED Weighted: 0.20Np Likeness Score: 1.58

References

1. Liu Y, Carreras CW, Claypool M, Myles DC, Shaw SJ..  (2011)  The role of the 4''-hydroxyl on motilin agonist potency in the 9-dihydroerythromycin series.,  21  (12): [PMID:21570844] [10.1016/j.bmcl.2011.04.078]

Source